PSMA PET/CT-Guided SABR for Oligometastatic Prostate Cancer

被引:0
|
作者
不详
机构
关键词
D O I
暂无
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
引用
收藏
页码:16N / 16N
页数:1
相关论文
共 50 条
  • [1] PSMA PET/CT-Guided RT in Oligometastatic PCa
    不详
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2019, 60 (05) : 14N - 14N
  • [2] PSMA-PET/CT-guided External Beam Radiotherapy of Osseous Metastases in an Oligometastatic Prostate Cancer Setting
    Sheikh, G. T.
    Rogowski, P.
    Zacherl, M. J.
    Unterrainer, L. M.
    Wenter, V.
    Dekorsy, F. J.
    Tiling, R.
    Pfluger, T.
    Unterrainer, M.
    Rubenthaler, J.
    Cyran, C. C.
    Bartenstein, P.
    Li, M.
    Beyer, L.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2022, 49 (SUPPL 1) : S270 - S270
  • [3] Adding ADT to PSMA-PET/CT-guided SBRT for oligometastatic prostate cancer improves distant progression-free survival
    Mercier, C.
    Billiet, C.
    Strijbos, M.
    Van den Mooter, T.
    Vandaele, F.
    Joye, I.
    Buys, A.
    Rypens, C.
    Oeyen, S.
    Van Laere, S. J.
    Vermeulen, P.
    Dirix, P.
    [J]. ANNALS OF ONCOLOGY, 2019, 30 : 342 - 342
  • [4] PSMA-PET is superior to choline-PET based SABR for ADT deferral in oligometastatic prostate cancer
    Deijen, C.
    Vrijenhoek, G.
    Vogel, W.
    Moonen, L.
    Pos, F.
    Van der Poel, H.
    Borst, G.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2020, 152 : S622 - S622
  • [5] Prostate-specific membrane antigen (PSMA) PET-CT guided radiotherapy in oligometastatic prostate cancer.
    Engels, Benedikt
    Guler, Ozan Cem
    Onal, Cem
    De Ridder, Mark
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (06)
  • [6] PSMA-PET GUIDED METASTASIS DIRECTED THERAPY FOR OLIGOMETASTATIC PROSTATE CANCER
    Ghaffar, Umar
    Sharma, Vidit
    Reitano, Giuseppe
    Basourakos, Spyridon P.
    Henning, Grant M.
    Ahmed, Mohamed E.
    Deol, Ekamjit S.
    Johnson, Geoffrey B.
    Andrews, Jack
    Kwon, Eugene D.
    Karnes, Robert J.
    [J]. JOURNAL OF UROLOGY, 2024, 211 (05): : E1006 - E1007
  • [7] Nodal and osseous oligometastatic prostate cancer: a cohort including the introduction of PSMA-PET/CT-guided stereotactic and hypofractionated radiotherapy with elective nodal therapy
    Gawish, Ahmed
    Walke, Matthias
    Rollich, Burkard
    Ochel, Hans-Joachim
    Brunner, Thomas B.
    [J]. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2023, 149 (07) : 3937 - 3949
  • [8] Nodal and osseous oligometastatic prostate cancer: a cohort including the introduction of PSMA-PET/CT-guided stereotactic and hypofractionated radiotherapy with elective nodal therapy
    Ahmed Gawish
    Matthias Walke
    Burkard Röllich
    Hans-Joachim Ochel
    Thomas B. Brunner
    [J]. Journal of Cancer Research and Clinical Oncology, 2023, 149 : 3937 - 3949
  • [9] Oligometastatic Prostate Cancer as detected with PSMA PET/CT; Impact on Treatment Strategies
    Alsagheer, Atheel
    Temsah, Peter
    Abdalla, Ahmed
    Gu, Lin
    Green, Aileen
    Muzaffar, Razi
    Osman, Medhat
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2023, 64
  • [10] PSMA-PET/CT for guidance and response assessment of SABR for prostate cancer oligometastases
    Dirix, P.
    Mercier, C.
    Billiet, C.
    Vermeulen, P.
    Oeyen, S.
    Van Laere, S.
    Huget, P.
    Verellen, D.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2019, 133 : S821 - S822